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Abstract 
Background: This experiment was conducted to evaluate the effects of the specific egg yolk immunoglobulin (IgY) 
on reducing the defects of experimental aflatoxicosis in broilers. Materials and Methods: In a completely 
randomized design, a total of 128 Ross 308 broiler chicks were used in 4 treatments, 4 replicates and 8 observations 
(chicks) for 42 days.  Treatments were: 1) control; 2) diet containing 1 ppm aflatoxin B1; 3) diet contaminated with 1 
ppm aflatoxin B1 + 0.75 % of egg yolk containing IgY; 4) diet contaminated with 1 ppm aflatoxin B1 + 1.5 % of egg 
yolk containing IgY. Results: The results showed that the use of aflatoxin containing diet significantly increased 
the feed conversion ratio, serum cholesterol concentration, serum gamma-glutamyl transferase (GGT), and 
aspartate aminotransferase (AST). Also, experimental aflatoxicosis resulted in reduced feed intake, weight gain, 
serum total protein and albumin concentrations (p<0.05); as well as the liver histopathologic lesions. IgY 
containing egg yolk (0.75% and 1.5%) added to the contaminated ration improved feed intake, weight gain and 
feed conversion ratio compared to treatment 2 (p<0.05). Compared to treatment 2, serum cholesterol 
concentration decreased while total protein concentration increased in treatments 3 and 4 (p<0.05). Liver tissue 
was approximately normal with mild effects on hepatocytes and mild cytoplasmic changes in chicks receiving 
treatments 3 and 4. Conclusion: It can be concluded that specific IgY is effective in reducing the defects of 
experimental aflatoxicosis as well as improving performance in broilers. 
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Aflatoxin B1 (AFB1) is one of the most hepatotoxic, 
genotoxic, and immunotoxic toxins to humans and 
animals. According to the International Agency for 
Research on cancer reports AFB1 is classified as the 
most important human carcinogen with no 
recognized safe dose (1). The toxic effect of AFB1 
may be also attributed to its enhancement of the 
reactive oxygen species (ROS) level in living cells, 
which may attack lipids, proteins, and nucleic acids 
(2). Although many methods, including physical, 
chemical, and biological methods have been tried to 
degrade the AFB1, most of these processes have led to 
the formation of toxic residues or derivatives and 
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consequently reduced the food’s nutritional values 
and organoleptic qualities (3). 
Hens egg yolk immunoglobulin (IgY), is composed 
of two light chains and two heavy chains, like 
mammalian counterpart IgG (4). However, IgY can 
neither activate the mammalian complement system 
nor interact with human Fc receptors and mammalian 
rheumatoid factors. Additionally, chickens can 
produce a strong immune response against 
mammalian antigens owing to the phylogenetic 
distance between mammals and birds (5). Because of 
these advantages, IgY has been used for the 
treatment of various gastro enteric infectious diseases 
and against macromolecular protein toxins such as 
Shiga toxin, ricin toxin, botulinum toxins, and viper 
venom (6). IgY antibodies have many advantages 
over IgG antibodies such as strong avidity, scalable 
productivity, low assay background, and applicability 
to many immunoassays providing a strategy for 
improvement of assay performance and accuracy. 
Therefore, the purpose of this study was to evaluate 
the possibility of using specific IgY against aflatoxin 
B1 to reduce the effects of experimental aflatoxicosis 
on blood biochemistry and liver histopathology of 
broiler chicks. 
Methods 
Ethical approval. The research was carried out at the 
University of Birjand (the poultry research farm) in 
July 2017. 
Toxin production. In the in vitro stage, Aflatoxin B1 
was produced by culture of Aspergillus parasiticus 
(NRRL 2999) on potato dextrose agar. Then the 
AFB1 production on rice was done according to the 
method described by Shotwell et al. (7). The 
concentration of Aflatoxin B1 was measured (75.4 
ppm) with HPLC (Testa Quality Control 
Laboratory, Mashhad, Iran).  
Bird immunization and IgY production. 
Immunization of laying hens and production of IgY 
was performed using the conjugated aflatoxin B1-
bovine serum albumin (Sigma, Germany). The 
injection was carried out in three stages at 14 days 
intervals. Injections were associated with 0.2 ml of 
complete Freund’s adjuvant in the first and 
incomplete Freund's adjuvant in subsequent 
injections. In the first and second injections, 200 
micrograms and in the third injection, 100 micrograms 
of the conjugate per bird was used. 14 days after the 
first injection, daily eggs were obtained and kept 
refrigerated (8). 
Experimental model. In the in vivo stage one-day-old 
Ross’s vaccinated broilers were obtained from a local 
commercial hatchery. One hundred twenty-eight 
chicks were randomly distributed to 4 dietary groups 
with 4 replicates of 8 chicks in each. Water and feed 
were available ad libitum. The experimental 
treatments were: 1) control; 2) diet containing 1 ppm 
aflatoxin B1 (contaminated control); 3) diet 
contaminated with 1 ppm aflatoxin B1 + 0.75 % of 
egg yolk containing IgY; 4) diet contaminated with 1 
ppm aflatoxin B1 + 1.5 % of egg yolk containing IgY. 
The average body weight gain and feed consumption 
were calculated during the experimental period.   
Blood chemical and histopathology. At the end of the 
trial, when broilers were 42 days old, 8 birds per 
treatment were randomly selected for blood collection 
from the wing vein for biochemical analysis. Blood 
was centrifuged at 2500 × g for 15 minutes and the 
serum separated and preserved at -20°C until 
biochemical analyses. Serum concentrations of total 
protein (TP), albumin (ALB), aspartate 
aminotransferase (AST), cholesterol (CHOL), 
triglyceride (TG), high density lipoprotein (HDL) and 
low density lipoprotein (LDL) were determined using 
an automatic analyzer (Gesan Chem 200, Italy) with 
commercial test kits (Pars Azmoon, Iran). After blood 
collection, the 8 previously selected birds were 
euthanized for pathological examination. Liver tissue 
samples were collected in 10% neutral buffered 
formalin. Upon fixation, samples were dehydrated in 
graded alcohol series, cleared in xylene, and 
embedded in paraffin wax. Ten-µm sections were cut 
and stained with hematoxylin and eosin (H&E; 
Thermo Shandon, 15275, USA) (9). 
Statistical analysis. Data were subjected to statistical 
analysis using the general linear model procedure of 
SAS software (10). Treatment means showing 
significant differences in the one-way analysis of 
variance were compared using Tukey’s general linear 
model test. All the statements of significance were 
based on the 0.05 probability level.  
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Results 
Performance. The effect of different treatments on 
feed intake, body weight gain and feed conversion 
ratio in the starter (1 to 10 days), grower (11 to 24 
days), finisher (25-42 days) and entire period (1 to 42 
days) is shown in Table 1. Contamination of the feed 
with 1 mg kg-1 of AFB1 reduced the feed intake of 
broiler chicks in grower, finisher, and the entire 
period of the experiment, which was significantly 
different from the control treatment (p<0.05). Adding 
egg yolks containing specific IgY to the 
contaminated control improved the feed consumption 
of broilers compared to the treatment 2 during the 
starter, finisher, and the entire period of the 
experiment (p<0.05). The addition of 1.5% egg yolk 
containing specific IgY to the contaminated diet 
(treatment 4) resulted in the highest feed intake 
which had a significant difference compared to the 
contaminated control group (p<0.05). Feeding chicks 
by contaminated feeds (1 mg kg-1 of AFB1) showed a 
significant weight loss in all experimental periods 
compared to the control group. IgY in the egg yolk 
added to the contaminated control group caused an 
increase in the weight of the broilers compared to the 
contaminated control treatment in all experimental 
periods (p<0.05). The highest weight gain in broiler 
chicks belonged to the treatment received 1.5% of egg 
yolk containing specific IgY, which is significantly 
higher than the contaminated control group in the 
starter, grower, finisher, and the entire of the 
experiment (p<0.05). Contamination of chicken feed 
with 1 mg kg-1 of AFB1 increased feed conversion 
ratio compared to the control group (p<0.05). Using 
IgY effectively reduced the effects of aflatoxin. Egg 
yolk containing immunized IgY against AFB1 at the 
levels of 0.75 and 1.5% reduced the feed conversion 
ratio compared with the contaminated control 






4 3 2 1  
2.53 0.0812 160.30 157.90 163.50 168.50 1-10 
Feed Intake 
(gr/period) 
28.26 0.0015 1186.69a 1113.44a 977.78b 1127.47a 11-24 
47.15 0.0001 2236.09a 2105.94a 1727.81b 2165.47a 25-42 
50.48 0.0001 3591.53a 3388.13a 2874.34b 3461.69a 1-42 
2.94 0.0309 126.56a 121.87ab 113.09b 116.09ab 1-10 
Body Weight 
Gain (gr/period) 
15.72 0.0010 762.19a 758.59a 650.44b 722.50a 11-24 
30.07 0.0001 1271.22a 1257.19a 795.52b 1178.25a 25-42 
36.50 0.0001 2159.97a 2137.66a 1562.05b 2013.84a 1-42 
0.03 0.0282 1.33b 1.38a 1.45ab 1.49a 1-10 
Feed Conversion 
Ratio (gr/gr) 
0.04 0.3602 1.55 1.46 1.50 1.56 11-24 
0.04 0.0001 1.76b 1.67b 2.17a 1.83b 25-42 
0.02 0.0001 1.64bc 1.58c 1.84a 1.71b 1-42 
a,b Within the same row, means with different letters are significantly different. 
*1) control; 2) diet containing 1 ppm aflatoxin B1; 3) diet contaminated with 1 ppm aflatoxin B1 + 0.75 % of egg yolk containing IgY; 
4) diet contaminated with 1 ppm aflatoxin B1 + 1.5 % of egg yolk containing IgY. 
 
Table2. Effect of different treatments on serum lipid, protein and liver enzymes (mg/dl) in broiler chicks at 42 days 
CHOL TG HDL LDL AST ALB GGT TP Treatments* 
127.50ab 91.75 74.50 35.00 301.75ab 1.55a 23.50 2.60a 1 
154.75a 96.75 79.25 43.00 279.50b 1.35ab 23.50 2.15ab 2 
126.33ab 85.33 76.00 34.50 344.33ab 1.30b 25.00 1.96b 3 
119.00b 89.50 75.66 30.33 360.67a 1.46ab 26.33 2.40ab 4 
0.0216 0.4473 0.6866 0.0179 0.0184 0.0305 0.3943 0.0145 P.Value 
7.24 12.32 2.79 3.41 16.83 0.05 1.31 0.12 SEM± 
a, b The mean of the letters in different columns is statistically significant. 
*1) control; 2) diet containing 1 ppm aflatoxin B1; 3) diet contaminated with 1 ppm aflatoxin B1 + 0.75 % of egg yolk containing IgY; 
4) diet contaminated with 1 ppm aflatoxin B1 + 1.5 % of egg yolk containing IgY.
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treatment during the finisher and the entire periods of 
the experiment (p<0.05). 
Blood biochemical. The effect of experimental 
treatments on proteins, lipids and serum enzymes of 
broiler chicks is presented in Table 2. The results 
indicate that the highest level of blood cholesterol 
observed in broilers fed 1 mg kg-1 of 
AFB1(contaminated control) chickens. Egg yolk 
anti-AFB1 immunoglobulin reduced serum 
cholesterol content in broilers compared with the 
contaminated control group. The lowest serum 
cholesterol belonged to the treatment with 1.5% of 
immunized egg yolk, which was significantly lower 
than that of contaminated control (p<0.05). 
Triglycerides concentration in different treatments 
did not show a significant difference. A numerical 
increase observed in serum triglyceride concentration 
of chickens fed 1 mg kg-1 of AFB1. High-density 
lipoprotein (HDL) and low-density lipoprotein 
(LDL) concentrations were not significantly different 
between treatments. Serum concentration of aspartate 
aminotransferase (AST) enzyme increased by 1 mg 
kg-1 of AFB1, which is significantly different from 
control treatment (p<0.05). Serum total protein and 
albumin concentration were different among 
experimental treatments. The lowest total protein and 
albumin concentrations observed in chickens fed 
aflatoxin, showing a significant difference (p<0.05) 
compared to control treatment. Specific IgY in egg 
yolks added to the contaminated control diet at levels 
of 0.75 and 1.5%, led to a numerical increase in total 
protein and albumin content of broiler chicks in 
comparison with the contaminated control group. 
There was no significant difference in serum 
concentration of gamma glutamine transferase enzyme 
(GGT) between treatments. 
Histopathology. Pathological photomorphography of 
the liver tissue in broilers receiving various 
experimental diets is shown in Fig-1. At the end of the 
experimental period (day 42), liver tissue of the 
broilers fed aflatoxin-infected ration showed the 
penetration of mononuclear cells in portal areas, 
widespread destruction, cytoplasmic cavities and 
decayed fat in hepatocytes. Liver tissue was 
approximately normal with mild effects on 
hepatocytes and mild cytoplasmic changes in chicks 
receiving treatments 3 and 4. Supplementation of diets 
contaminated with one mg kg-1 aflatoxin by the 
specific immunoglobulin (0.75% and 1.5%), showed 
the high ability of the IgY to absorb Aflatoxin B1 and 
reduce its effects on the liver of the broilers.  
Discussion 
Feed intake and weight gain (Table 1) were 
significantly different between treatments (P<0.01), 
and the values were lower in treatment negative 
control, as expected, with declines of 50 and 35%, 
respectively, when compared with positive control. 
These reductions were due to the high absorption of 
AFB1 by the gastrointestinal tract. The metabolism of 
this compound in the liver generates toxic metabolites 
that cause liver injury and inhibition of protein 
synthesis, culminating in anorexia, as also reported by 
Yunus et al. (11). Studies using only AFB1 has 
demonstrated the impact of this mycotoxins on animal 
performance. In this study, the highest reductions can 
be associated with AFB1, as evidenced by Miazzo and 
his colleagues, who used levels of 2.5 mg kg-1 of 
AFB1 and reported an 11% reduction in weight gain 
of broilers from 21 to 42 days (12).  
Dietary exposure to AFB1 and other aflatoxins leads 
to lower weight gain and absolute body weights in 
both chickens and turkeys (13). Reduced feed intake 
and decreased efficiency of nutrient usage both 
contribute to this impaired growth during aflatoxicosis 
(13). Feed efficiency was significantly suppressed (P< 
0.05) in 1000 µg kg-1 AF fed group during all the 
three periods. Poor feed conversion noted with the 
 
Figure 1. Liver histopathology in different treatments. 1) control; 2) 
diet containing 1 ppm aflatoxin B1; 3) diet contaminated with 1 ppm 
aflatoxin B1 + 0.75 % of egg yolk containing IgY; 4) diet 
contaminated with 1 ppm aflatoxin B1 + 1.5 % of egg yolk 
containing IgY.(Arrows show widespread destruction, cytoplasmic 
cavities and decayed fat). 
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AFB1 seems to have mediated decreased nutrient 
utilization. Yegani et al. (14) with broiler breeders 
showed that chickens are sensitive to the feeding of 
mycotoxins with respect to feed efficiency. 
AFB1 adducts with biomolecules cause damage to 
hepatocytes that impairs metabolic functions of the 
liver during AFB1 exposure. This is exemplified by 
AFB1-reduced total serum protein levels, as the liver 
is responsible for production of most circulating 
proteins (13). Aflatoxicosis negatively affects 
albumin, globulin, cholesterol, and triglyceride levels 
in serum (15). Protein content likely declines because 
AFB1-DNA adducts inhibit transcription or 
translation and AFB1-lysine adducts result in protein 
degradation or excretion. Reduced synthesis of 
enzymes in the liver would have systemic effects on 
poultry metabolism (16). Quist et al. (17) showed 
that total protein levels are significantly reduced in 
turkeys poisoned with Previous studies performed 
with high levels of AF (2.5-5 mg/kg diet) showed 
significant decreases in serum total protein and 
albumin. The results also revealed that treatment with 
IGY prevented changes in AST activity, supporting 
the idea that these IGY may provide protection 
against toxic effects of AFB1. The addition of IGY to 
the AFB1 diet prevented the decrease in these AF-
sensitive serum proteins in the present study.  
Triglyceride levels, in turn, were not influenced by 
mycotoxins. These data agree with Maciel et al. (18), 
who reported no differences in plasma triglyceride 
content between the positive and negative control 
containing 5 mg kg-1 of aflatoxins. 
The present study clearly indicates significant 
increase in cholesterol concentration in the aflatoxin-
treated. Exact mechanism for a significant rise in 
cholesterol content in liver is not clearly understood. 
This might be due to fatty infiltration and 
degeneration of hepatocytes during aflatoxicosis as 
toxin is fat soluble. Once brought to the liver through 
hepatic portal system, fat present in the liver cells 
might dissolve toxin and retain it. Verma et al. (19) 
have reported significant rise in cholesterol in 
aflatoxinfed rabbits. Rastogi et al. (20) also reported 
increased cholesterol in rat liver.  
AFB1 is known to be hepatotoxic and causes genetic 
damage (21). In the present study, significant 
increases in the levels of AST and ALT were 
observed upon treatment with AFB1 during 42 days. 
This increase in the values of serum AST and ALT 
might be due to hepatotoxic effects of AFB1 which is 
in agreement with the findings of Fani Makki et al. 
(22).  
Critical to protein synthesis, enzymatic metabolism 
and detoxification processes, the liver is the primary 
site of AFB1 activation and therefore toxicity (23). 
Aflatoxicosis in poultry is characterized by an 
enlarged, pale, and friable liver although relative liver 
weight can initially decrease, longer exposure to 
dietary AFB1 raises the relative weight of the liver and 
causes pale or yellowed pigmentation (13). Both acute 
and chronic AFB1 consumption by poultry cause other 
hepatic lesions. Common histopathological signs of 
AFB1-induced liver damage include focal necrotic 
hepatocytes or hemorrhages (24). Acute damage 
initiates inflammatory responses and leads to 
leukocyte infiltration and proliferation in the liver 
(25). In poultry, chronic AFB1 consumption is 
mutagenic and leads to remodeling of liver tissues. 
Hyperplasia of bile duct epithelial cells or oval cells 
develops first, followed by periportal fibrosis and 
nodular tissue regeneration (26). 
Conclusion 
It can be concluded that specific IgY is effective in 
reducing the defects of experimental aflatoxicosis as 
well as improving performance in broilers. 
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